Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 155.00
Bid: 150.00
Ask: 160.00
Change: 5.00 (3.33%)
Spread: 10.00 (6.667%)
Open: 150.00
High: 155.00
Low: 155.00
Prev. Close: 150.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Thomas Cook Plunges On Rescue Deal Talks

Fri, 12th Jul 2019 10:35

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------BHP Group, up 1.5%. The Anglo-Australian miner was upgraded to Neutral from Underweight by JPMorgan. ----------FTSE 100 - LOSERS----------Hiscox, down 5.0%. The insurer said pretax profit for the first half of 2019 is estimated to be between USD150 million and USD170 million amid continued deterioration in insurance market from 2018 catastrophe events, including Typhoon Jebi in Japan and Hurricane Michael in the US state of Florida. Hiscox said the scale of deterioration in the market has been significant, with industry loss estimates having increased materially since the two damaging storms. Hiscox has strengthened reserves for prior year claims from Typhoon Jebi, Hurricane Michael, and for the risk excess book by USD40 million. It expects reserve releases in the first half to be materially lower than last year due to the absence of prior-year releases from Hurricanes Harvey, Irma and Maria, which totalled USD25 million.----------FTSE 250 - WINNERS----------Sophos, up 5.0%. The cybersecurity firm said it is well positioned for growth despite swinging to loss in the first quarter of its current financial year. Sophos said it swung to a pretax loss of USD4.0 million for the three months to the end of June compared to a pretax profit of USD7.3 million reported in the first quarter last year. More positively for Sophos, its adjusted operating profit increased to USD24.1 million from USD21.9 million and its renewal rate as of June 30 stood at 118% compared to 115% a year ago. Revenue, meanwhile, increased by 2.7% to USD180.2 million from USD175.5 million year-on-year. Sophos explained that in the first quarter its subscription revenue growth of 10% in constant currency offset an 11% fall in hardware revenue. ----------easyJet, up 2.8%. Berenberg raised the budget airline to Buy from Hold.----------FTSE 250 - LOSERS----------Senior, down 2.3%. Peel Hunt downgraded the aerospace and defence engineer to Hold from Add. ----------Ashmore Group, down 1.5%. The emerging markets-focused asset manager said healthy client activity, good returns from emerging markets and business diversification led to a 7.6% quarter-on-quarter rise in assets under management for the final three months of financial 2019. The company's assets under management increased by USD6.5 billion during the three months to June 30 to USD91.8 billion from USD85.3 billion as at March 31, with net inflows contributing USD3.3 billion and positive investment performance another USD3.2 billion. The rise in assets also was attributed to improved market conditions such as the easing of US and China trade tensions, central banks in Europe and US turning more dovish, and the weakening of the US dollar. However, Peel Hunt cut the stock to Add from Buy after a strong share price performance. The stock is up 40% so far in 2019. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Faron Pharmaceuticals, up 18%. The clinical stage drug developer said its MATINS study of nine cancer patients is progressing well, and it is planning to expand the clinical trial to more countries. Faron is undertaking the trial to investigate the safety and effectiveness of Clevegen, the company's cancer immunotherapy. Faron reached its planned Clevegen dosing of 10 milligrams per kilogram in June and said this was "well tolerated" by patients. It plans to propose an increase of the test dosage to 20 milligrams per kilogram to the trial's independent data monitoring board. The MATINS study is investigating five cancers: cutaneous melanoma, hepatobiliary, pancreatic, ovarian and colorectal. Altogether these cancers have two million annual cases worldwide. Of the nine patients being studied across three clinical sites in the UK and Finland, two subjects have demonstrated anti-cancer responses. ----------OTHER MAIN MARKET AND AIM - LOSERS----------Thomas Cook, down 43%. Shares in the travel operator hit an all-time of 6.0 pence with almost GBP80 million wiped off its total market value as the company enters rescue deal talks with its largest shareholder Fosun. Chinese investor Fosun, which holds an 18% stake in the group, could offer a GBP750 million cash injection into the company, which has suffered from falling demand for package holidays and high debt. Fosun said that it, along with Thomas Cook's "core lending banks", are considering the proposal to invest capital into the troubled firm. Thomas Cook said the investment - which will likely comprise a capital injection and new financing facilities - will see a reorganisation of the company's Tour Operator and Airline business. This will lead to Fosun owning a "significant" minority interest in Thomas Cook's Airline. The iconic UK high street travel agent added that its 2019 summer programme is 75% sold - slightly ahead of the year before - but its underlying earnings in the second half will be behind the year before due to the "uncertain consumer environment" in the UK. ----------Lookers, down 22%. The car dealer said it expects to see a drop in profit for the first half of 2019, and expects profit for the full year to be below previous expectations. Although trading in the first quarter to the end of March was positive, the second quarter ended June 30 was challenging, as the UK new car market continued its decline with registrations down by 4.6%. In the used car market, weaker demand led to increased margin pressure, especially in June, during which Lookers said it had to take "a disciplined approach" to managing stock. As a result, underlying pretax profit for the six months to the end of June is expected to be GBP32 million, down 25% from GBP43 million a year before. Looking ahead, Lookers expects the challenging conditions to continue into the second half, stoked by continued weakness in UK consumer confidence due to political and economic uncertainty.----------

More News
24 Apr 2023 14:21

Faron Pharmaceuticals test data shows efficacy of bexmarilimab

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said further data from its Phase I/II MATINS study of bexmarilimab has indicated the efficacy and safety of the immunotherapy in solid tumours.

Read more
17 Apr 2023 16:34

TRADING UPDATES: Anglo Asian gold output down; Faron hails antibody

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
29 Mar 2023 10:42

Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO

(Alliance News) - Faron Pharmaceuticals Ltd on Wednesday said it has appointed James O'Brien as its new chief financial officer, effective from Monday next week, succeeding Toni Hanninen.

Read more
29 Mar 2023 09:38

Faron Pharmaceuticals names James O'Brien as CFO

(Sharecast News) - Drug discovery and development company Faron Pharmaceuticals has tapped James O'Brien to take over as its new chief financial officer.

Read more
22 Mar 2023 17:12

Faron Pharmaceuticals gets positive feedback from FDA meeting

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals said on Wednesday that it had received positive feedback from the US Food and Drug Administration (FDA) on the development of its precision immunotherapy asset 'bexmarilimab'.

Read more
17 Mar 2023 15:42

UK shareholder meetings calendar - next 7 days

Monday 20 March 
Aukett Swanke Group PLCGM re proposed acquisition of Torpedo Factory Group Ltd
Pantheon Resources PLCAGM
Voyager Life PLCGM re subscription and fundraise
Tuesday 21 March 
BlackRock Sustainable American Income Trust PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
React Group PLCAGM
Starvest PLCAGM
Sureserve Group PLCAGM
Wynnstay Group PLCAGM
Zamaz PLCGM re terms and conditions modification
Wednesday 22 March 
abrdn Private Equity Opportunities Trust PLCAGM
Asia Strategic Holdings LtdAGM
Circle Property PLCEGM re final disposal and cancellation
Genel Energy PLCAGM
Harmony Energy Income Trust PLCAGM
Titon Holdings PLCAGM
Thursday 23 March 
Crest Nicholson Holdings PLCAGM
Driver Group PLCAGM
Goldplat PLCAGM
Hardide PLCAGM
Idox PLCAGM
Zaim Credit Systems PLCGM re director removal and name change
Friday 24 March 
Faron Pharmaceuticals LtdAGM
In The Style Group PLCGM re sale of only subsidiary; becoming cash shell named Itsum PLC
Kitwave Group PLCAGM
Midatech Pharma PLCGM re cancellation of the admission to trading on AIM and name change
SME Credit Realisation Fund LtdEGM re cancellation of the company's listing
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Mar 2023 11:53

Faron Pharmaceuticals annual loss widens on higher research costs

(Alliance News) - Faron Pharmaceuticals Ltd on Friday reported a widened loss in 2022 as it ramped up its research & development efforts.

Read more
24 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Monday 27 February 
Associated British Foods PLCTrading Statement
Beeks Financial Cloud Group PLCHalf Year Results
Bunzl PLCFull Year Results
Centralnic Group PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
DX Group PLCHalf Year Results
GlobalData PLCFull Year Results
Greencoat Renewables PLCFull Year Results
Kosmos Energy LtdFull Year Results
Quartix Technologies PLCFull Year Results
RHI Magnesita NVFull Year Results
Senior PLCFull Year Results
Tuesday 28 February 
abrdn PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Bluefield Solar Income Fund LtdHalf Year Results
boohoo Group PLCFull Year Results
Cap-XX LtdHalf Year Results
Croda International PLCFull Year Results
Dalata Hotel Group PLCFull Year Results
Derwent London PLCFull Year Results
Hutchmed (China) LtdFull Year Results
Intertek Group PLCFull Year Results
Kitwave Group PLCFull Year Results
Man Group PLCFull Year Results
McBride PLCHalf Year Results
Morgan Advanced Materials PLCFull Year Results
Ocado Group PLCFull Year Results
Princess Private Equity Holding LtdFull Year Results
Rotork PLCFull Year Results
Serco Group PLCFull Year Results
St James's Place PLCFull Year Results
S-Ventures PLCFull Year Results
Travis Perkins PLCFull Year Results
Uniphar PLCFull Year Results
Unite Group PLCFull Year Results
Videndum PLCFull Year Results
XP Power LtdFull Year Results
Wednesday 1 March 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
GetBusy PLCFull Year Results
Glenveagh Properties PLCFull Year Results
Global Invacom Group LtdFull Year Results
Haydale Graphene Industries PLCHalf Year Results
International Personal Finance PLCFull Year Results
Nichols PLCFull Year Results
Permanent TSB Group Holdings PLCFull Year Results
Persimmon PLCFull Year Results
Rathbones Group PLCFull Year Results
Reckitt Benckiser Group PLCFull Year Results
Ricardo PLCHalf Year Results
Weir Group PLCFull Year Results
Thursday 2 March 
Alfa Financial Software Holdings PLCFull Year Results
Apax Global Alpha LtdFull Year Results
Beazley PLCFull Year Results
Brooks Macdonald Group PLCHalf Year Results
Cairn Homes PLCFull Year Results
Capita PLCFull Year Results
Capital & Regional PLCFull Year Results
Coats Group PLCFull Year Results
CRH PLCFull Year Results
Flutter Entertainment PLCFull Year Results
Funding Circle Holdings PLCFull Year Results
Grafton Group PLCFull Year Results
Haleon PLCFull Year Results
Hunting PLCFull Year Results
ITV PLCFull Year Results
London Stock Exchange Group PLCFull Year Results
Melrose Industries PLCFull Year Results
Metro Bank PLCFull Year Results
National Express Group PLCFull Year Results
PPHE Hotel Group LtdFull Year Results
Schroder AsiaPacific Fund PLCFull Year Results
Schroders PLCFull Year Results
Spire Healthcare Group PLCFull Year Results
Taylor Wimpey PLCFull Year Results
Tritax Big Box REIT PLCFull Year Results
Tyman PLCFull Year Results
Vesuvius PLCFull Year Results
Friday 3 March 
Avation PLCHalf Year Results
Faron Pharmaceuticals LtdFull Year Results
IMI PLCFull Year Results
Pacific Horizon Investment Trust PLCHalf Year Results
Pearson PLCFull Year Results
Rightmove PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
27 Jan 2023 18:56

TRADING UPDATES: Diaceutics wins two deals; Faron proposes placing

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
27 Jan 2023 10:28

IN BRIEF: Faron Pharmaceuticals raises EUR12 million via shares

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical drug discovery and development company - Raises EUR12.0 million via placing of 3.7 million shares at the issue price of EUR3.25 each. Faron says that with these proceeds and the current level of activity, it has sufficient working capital into the third quarter of 2023.

Read more
27 Jan 2023 10:11

AIM WINNERS & LOSERS: Faron Pharmaceuticals raises EUR12 million

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
16 Jan 2023 16:26

TRADING UPDATES: Tungsten West 'largest Western tungsten producer'

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Dec 2022 12:06

Faron Pharmaceuticals sees patient remission in immunotherapy trials

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it was encouraged by promising early data from trials for its investigative precision immunotherapy, which aims to provide permanent immune stimulation for difficult-to-treat cancers by targeting myeloid cell function.

Read more
1 Dec 2022 21:42

TRADING UPDATES: Renalytix hails trial results; Kingswood buys JFP

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
18 Nov 2022 19:49

TRADING UPDATES: Joules nomad resigns; Pharma C loss narrows

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.